Top 10 Developments in Lupus Nephritis

被引：0
作者：
Teresa K. Chen
Derek M. Fine
机构：
[1] The Johns Hopkins University School of Medicine,Division of Nephrology
来源：
Current Rheumatology Reports | 2013年 / 15卷
关键词：
Lupus nephritis; Kidney; Proliferative lupus nephritis; Membranous lupus nephritis; Renal transplantation; Induction therapy; Maintenance therapy; Systemic lupus erythematosus; SLE; Mycophenolate mofetil; Rituximab; Treatment; Multitargeted therapy; Epidemiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Lupus nephritis affects up to 60 % of patients with systemic lupus erythematosus and is associated with worse clinical outcomes. Traditionally, it has been treated with high-dose immunosuppression consisting of cyclophosphamide and prednisone; however, recent trials have demonstrated mycophenolate mofetil as a safe and effective alternative for both induction and maintenance of disease. Other progress has been made in our understanding of the pathogenesis of lupus nephritis, outcomes in renal transplantation, and associations with genetic risk factors. This review highlights key developments in our understanding of lupus nephritis over the past decade.
引用
收藏
相关论文
共 154 条
[1]  
Moroni G(1996)“Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritis Kidney Int 50 2047-53
[2]  
Quaglini S(2011)Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006 Arthritis Rheum 63 1681-8
[3]  
Maccario M(1986)Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs N Engl J Med 314 614-9
[4]  
Banfi G(1974)A double-blind controlled trial comparing cyclophosphamide, azathioprine and placebo in the treatment of lupus glomerulonephritis Arthritis Rheum 17 923-37
[5]  
Ponticelli C(2005)Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis N Engl J Med 353 2219-28
[6]  
Costenbader KH(2009)Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis J Am Soc Nephrol 20 1103-12
[7]  
Desai A(1998)Successful mycophenolate mofetil treatment of glomerular disease Am J Kidney Dis 31 213-7
[8]  
Alarcon GS(1999)Mycophenolate mofetil therapy in lupus nephritis: clinical observations J Am Soc Nephrol 10 833-9
[9]  
Austin HA(2000)Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group N Engl J Med 343 1156-62
[10]  
Klippel JH(2012)KDIGO clinical practice guideline for glomerulonephritis Kidney Int Supp 2 221-32
12345678910